000 | 01314 a2200349 4500 | ||
---|---|---|---|
005 | 20250514060537.0 | ||
264 | 0 | _c20030801 | |
008 | 200308s 0 0 eng d | ||
022 | _a1619-7070 | ||
024 | 7 |
_a10.1007/s00259-002-1004-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBiermann, M | |
245 | 0 | 0 |
_aShould high hTg levels in the absence of iodine uptake be treated? _h[electronic resource] |
260 |
_bEuropean journal of nuclear medicine and molecular imaging _cJan 2003 |
||
300 |
_a160-3 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aFalse Negative Reactions |
650 | 0 | 4 |
_aIodine Radioisotopes _xpharmacokinetics |
650 | 0 | 4 |
_aNeoplasm Metastasis _xdiagnosis |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xblood |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aRadionuclide Imaging |
650 | 0 | 4 |
_aThyroglobulin _xblood |
650 | 0 | 4 |
_aThyroid Neoplasms _xdiagnostic imaging |
650 | 0 | 4 | _aThyroidectomy |
650 | 0 | 4 |
_aWhole-Body Counting _xmethods |
650 | 0 | 4 | _aWithholding Treatment |
700 | 1 | _aSchober, O | |
773 | 0 |
_tEuropean journal of nuclear medicine and molecular imaging _gvol. 30 _gno. 1 _gp. 160-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00259-002-1004-1 _zAvailable from publisher's website |
999 |
_c12380876 _d12380876 |